Øâ¯ã˜â§ã™â€ Ù„ã™ë†ã˜â¯ Øâ²ã›å’ã˜â±ã™â€ Ùë†ã›å’ã˜â³ Ùâã˜â§ã˜â±ã˜â³ã›å’ Ùâã›å’ã™â€žã™â€¦ Johnny English Strikes Again 2018
Production AND APPLICATION OF ANGIOSTATINS FOR THE Handling OF OCULAR NEOVASCULAR DESEASES
Biotechnologia Acta ; fourteen(1):5-24, 2021.
Artigo em Inglês
| ProQuest Central | ID: covidwho-1136887
Abstruse
Angiostatins comprise a group of kringle-containing proteolytically-derived fragments of plasminogen/plasmin, which act equally strong inhibitory mediators of endothelial cells proliferation and migration. Angiostatins are involved in modulation of vessel growth in good for you tissues and various pathological conditions associated with aberrant neovascularization. The aim of the present paper was to summarize available information, including our own experimental data, on prospects of angiostatin application for handling of ocular neovascular diseases (OND), focusing on retinal pathologies and corneal injury. In particular, literature data on prospective and retrospective studies, clinical trials and creature models relating to the pathophysiology, investigation and management of OND are described. Special accent was made on the laboratory approaches of production of dissimilar angiostatin isoforms, as well as comparison of antiangiogenic capacities of native and recombinant angiostatin polypeptides. Several studies reported that angiostatins may completely abolish pathologic angiogenesis in diabetic proliferative retinopathy without affecting normal retinal vessel development and without exhibiting adverse side furnishings. Angiostatins accept been tested as a tool for corneal antiangiogenesis target therapy in order to manage diverse ocular surface pathological atmospheric condition induced by traumas, chemical burns, previous surgery, chronic contact lens clothing, autoimmune diseases, keratitis and viral infections (herpes, COVID-19), corneal graft rejection, etc. Among all known angiostatin species, isolated K5 plasminogen fragment was shown to display the well-nigh strong inhibitory action confronting proliferation of endothelial cells via triggering multiple signaling pathways, which atomic number 82 to cell death and resulting angiogenesis suppression. Application of adenoviral genetic construct encoding angiostatin K5 as a promising tool for OND treatment illustrates a bright case of upcoming revolution in local gene therapy. Further comprehensive studies are necessary to elucidate the clinical potential and optimal regimes of angiostatin-based intervention modalities for treating ocular neovascularization.Alternating abstractÃÂýóÃ'‚Ã'ÂÃ'‚ðÃ'‚øýø Ã'ÂÃ'‚ðýþòûÃ'ÂÃ'‚Ã'Å' Ã'‚Ã'€Ã'Æ'ÿÃ'Æ' úÃ'€Ã¸Ã½Ã³Ã»(ÃÅ¡)-òü1Ã'ÂýøÃ'… ÿÃ'€Ã¾Ã'‚õþû1Ã'‚øÃ'‡Ã½Ã¸Ã'… Ã'„Ã'€Ã°Ã³Ã¼ÃµÃ½Ã'‚Ã'ˆ ÿûð÷üÃ'ˆÃ¾Ã³ÃµÃ½/ÿûð÷üÃ'ˆÃ'Æ', Ã'Âú1 Ã'„Ã'Æ'ýúÃ'‰Ã¾Ã½Ã'Æ'Ã'ŽÃ'‚Ã'Å' Ã'Âú ÿþÃ'‚Ã'Æ'öÃ'ˆ Ã'ˆÃ¿Ã±Ã'Æ'òðûÃ'Å'Ã'ˆ üõôÃ'‚Ã'‚þÃ'€Ã¸ ÿÃ'€Ã¾Ã»1Ã'„õÃ'€Ã°Ã'†Ã¿ Ã'‚ð Mirpauii õýôþÃ'‚õûÃ'ˆÃ½Ã¸Ã'… úûóóøý. Òþýø ñõÃ'€Ã'Æ'Ã'‚Ã'Å' Ã'Æ'Ã'‡Ã°Ã'ÂÃ'‚Ã'Å' Ã'Æ' üþôÃ'Æ'ûÃ'ŽÃ²Ã°Ã½Ã'ˆ Ã'€Ã¾Ã'ÂÃ'‚Ã'Æ' Ã'ÂÃ'Æ'ôøø Ã'Æ' Ã'‚úðýøýðÃ'… ÷ð ýþÃ'€Ã¼Ã¸ Ã'‚ð Ã'€Ã'ŽÃ½Ã¸Ã'… ÿðÃ'‚þûþóÃ'ˆÃ½Ã¸Ã'… Ã'ÂÃ'‚ðýÃ'ˆ, ðÃ'ÂþÃ'†Ã'ˆÃ¾Ã²Ã°Ã½Ã¸Ã'… ÷ ðñõÃ'€Ã°Ã½Ã'‚ýþÃ'Ž ýõþòðÃ'ÂúÃ'Æ'ûÃ'ÂÃ'€Ã¸Ã·Ã°Ã'‰ÃµÃ'Ž. ÃÅ"õÃ'‚þÃ'Ž Ã'€Ã¾Ã±Ã¾Ã'‚ø ñÃ'Æ'ûþ Ã'Æ'÷ðóðûÃ'Å'ýõýýÃ' Ã½Ã°Ã'Âòýþ! Ä°HÃ'„þÃ'€Ã¼Ã°Ã'†Ã¸, Ã'„þÃ'€Ã¼Ã°Ã'†Ã¸, òúûÃ'ŽÃ'‡Ã°Ã'ŽÃ'‡Ã¸ òûðÃ'ÂÃ'‚ õúÃ'ÂÿõÃ'€Ã¸Ã¼ÃµÃ½Ã'‚ðûÃ'Å'HÄ° ôðÃ'ˆ aBTopÄ°B, Ã'‰Ã¾Ã´Ã¾ ÿõÃ'€Ã'ÂÿõúÃ'‚øò ÷ðÃ'ÂÃ'‚þÃ'ÂÃ'Æ'òðýýÃ' Ã°Ã½Ã³Ã'‚Ã'ÂÃ'‚ðÃ'‚øýÃ'Æ' ôûÃ' Ã»Ã'ˆÃ'Æ'òðýýÃ' Ã½ÃµÃ¾Ã²Ã°Ã'ÂúÃ'Æ'ûÃ'ÂÃ'€Ã½Ã¸Ã'… ÷ðÃ'…òþÃ'€Ã'ŽÃ²Ã°Ã½Ã'Å' þúð (ÃÂÃâ€"Þ). Ã“Ã¾Ã»à ¾Ã²Ã½Ã'Æ' Ã'Æ'òðóÃ'Æ' ÷þÃ'ÂõÃ'€ÃµÃ´Ã¶ÃµÃ½Ã¾ ýð ÿðÃ'‚þûþóÃ'ˆÃ'… cÃÂtkÃÂbkh Ã'‚ð Ã'Æ'Ã'ˆÃºÃ¾Ã´Ã¶ÃµÃ½HÄ° porÄ°BKH. Ãâ€"þúÃ'€ÃµÃ¼Ã°, þÿøÃ'Âðýþ ôðÃ'‚ Û1Ã'‚õÃ'€Ã°Ã'‚Ã'Æ'Ã'€Ã¸ Ã'ÂÃ'‚þÃ'Âþòýþ ÿõÃ'€Ã'ÂÿõúÃ'‚øòýøÃ'… Ã'‚ð Ã'€ÃµÃ'‚Ã'€Ã¾Ã'ÂÿõúÃ'‚øòýøÃ'… ôþÃ'ÂûÃ'‰Ã¶ÃµÃ½Ã'Å', úûÃ'ˆÃ'ˆÃ½Ã¸Ã'… òøÿÃ'€Ã¾Ã±Ã'Æ'òðýÃ'Å' i ÿðÃ'‚þÃ'„ÃÅ"þûþóÃ'ˆÃ½Ã¸Ã'… Ã'‚òðÃ'€Ã¸Ã½Ã½Ã¸Ã'… üþôõûõù, Ã'ÂÃ'‚òþÃ'€ÃµÃ½Ã¸Ã'… ôûÃ' Ã´Ã¾Ã'ÂûÃ'‰Ã¶ÃµÃ½Ã½Ã' Ã'‚ð ûÃ'ˆÃ'Æ'òðýýÃ' ÃÂÃâ€"Þ. ÞÃ'Âþñûøòøù ðúÃ'†ÃµÃ½Ã'‚ ñÃ'Æ'ûþ ÷Ã'€Ã¾Ã±Ã»ÃµÃ½Ã¾ ýð ûðñþÃ'€Ã°Ã'‚þÃ'€Ã½Ã¸Ã'… ÿÃ'‰Ã'…þôðÃ'… ôþ þÃ'‚Ã'€Ã¸Ã¼Ã°Ã½Ã½Ã' Ã'€Ã'ŽÃ½Ã¸Ã'… Ã'ŽÃ¾Ã'„þÃ'€Ã¼ ðýóÃ'‚Ã'ÂÃ'‚ðÃ'‚øýÃ'Æ', ð Ã'‚ðúþö ýð ÿþÃ'€Ã'ˆÃ½Ã'ÂýÃ'ˆ ðýÃ'‚øðýóÃ'‚óõýýøÃ'… òûðÃ'ÂÃ'‚øòþÃ'ÂÃ'‚õù ýðÃ'‚øòýøÃ'… Ã'‚ð Ã'€ÃµÃºÃ¾Ã¼Ã±Ã'ˆÃ°Ã½Ã'‚ýøÃ'… ÿþû1ÿõÿÃ'‚øôÃ'ˆ-ðýóÃ'‚Ã'ÂÃ'‚ðÃ'‚øÃ'ˆÃ². ôÃ'ˆ-ðýóÃ'‚Ã'ÂÃ'‚ðÃ'‚øÃ'ˆÃ². àõ÷Ã'Æ'ûÃ'Å'Ã'‚ðÃ'‚ø cepii ôþÃ'ÂûÃ'‰Ã¶ÃµÃ½Ã'Å' Ã'Âò1ôÃ'‡Ã°Ã'‚Ã'Å', Ã'‰Ã¾Ã°Ã½Ã³Ã'‚Ã'ÂÃ'‚ðÃ' øýø üþöÃ'Æ'Ã'‚Ã'Å' ÿþòý1Ã'ÂÃ'‚Ã'Ž ÿÃ'€Ã¸Ã³Ã'ˆÃ'‡Ã'Æ'òðÃ'‚ø ÿðÃ'‚þûþÿÃ'‡Ã½Ã¸Ã¹ ðýÿþóõýõ÷ ÷ð Ãâ€1ðñõTH4HOÃŽ TH4HOÃŽ ÿÃ'€Ã¾Ã»1Ã'„õÃ'€Ã°Ã'‚øòýþ1 Ã'€ÃµÃ'‚øýþÿðÃ'‚ø, ýõ òÿûøòðÃ'ŽÃ'‡Ã¸ ýð ýþÃ'€Ã¼Ã°Ã»Ã'Å'ýøù Ã'€Ã¾Ã·Ã²Ã¸Ã'‚þú Ã'ÂÃ'Æ'ôøý cÃÂtkÃÂbkh Ã'‚ð ýõ òøÃ'ÂòûÃ'ÂÃ'ŽÃ'‡Ã¸ ýõÃ'ÂÿÃ'€Ã¸Ã'ÂÃ'‚ûøòøÃ'… ÿþñÃ'ˆÃ½Ã¸Ã'… õÃ'„õúTÄ°B. ÃÂýÿþÃ'ÂÃ'‚ðÃ'‚øýø òøÿÃ'€Ã¾Ã±Ã¾Ã²Ã'Æ'Ã'ŽÃ'‚Ã'Å' Ã'Âú Ã'ˆÃ'ÂÃ'‚Ã'€Ã'Æ'üõýÃ'‚ ôûÃ' Ã'‚ðÃ'€Ã³ÃµÃ'‚ýþ! ðýÃ'‚øðýÿþóõýýþ! Tepami Ã'€Ã¾Ã³Ã'ˆÃºÃ¸ ÷ üõÃ'‚þÃ'Ž ûÃ'ˆÃ'Æ'òðýýÃ' Ã'€Ã'ŽÃ½Ã¾Ã¼Ã°Ã½Ã³Ã³Ã½Ã¸Ã'… ÿðÃ'‚þûþÿÃ'‡Ã½Ã¸Ã'… Ã'ÂÃ'‚ðÃ'ˆÃ² þÃ'‡Ã½Ã¾! ÿþòõÃ'€Ã'…Ã'ˆ, Ã'ÂÿÃ'€Ã¸Ã'‡Ã¸Ã½ÃµÃ½Ã¸Ã'… Ã'‚Ã'€Ã°Ã²Ã¼Ã°Ã¼Ã¸, XÃÂMÃÂ4HHMH þÿÃ'ˆÃ°Ã¼Ã¸, ÿþÿõÃ'€ÃµÃ´Ã½Ã'ˆÃ¸ þÿõÃ'€Ã°Ã'‚øòýøüø òÃ'‚Ã'€Ã'Æ'Ã'‡Ã°Ã½Ã½Ã'Âüø, ßÞáâèÃÂÃËœÃÅ" ÃÂÞáèÃÂïÃÅ" úþýÃ'‚ðúÃ'‚ýøÃ'… ûÃ'ˆÃ·, ðòÃ'‚þÃ'ˆÃ'Æ'ýýøüø ÷ðÃ'…òþÃ'€Ã'ŽÃ²Ã°Ã½Ã½Ã'Âüø, úõÃ'€Ã°Ã'‚øÃ'‚ðüø Ã'‚ð òÃ'„Ã'Æ'Ã'Âýøüø Ã'ˆÃ'„õúÃ'†Ã'ˆÃ¼Ã¸ (óõÃ'€Ã¿ÃµÃ'Â, COVID-19), òÃ'‰Ã'‚þÃ'€Ã³Ã½ÃµÃ½Ã½Ã'Âü Ã'‚Ã'€Ã°Ã½Ã'ÂÿûðýÃ'‚ðÃ'‚ð Ã'€Ã¾rÄ°BKH Ã'‚þÃ'‰Ã¾. áõÃ'€ÃµÃ´ ycix òÃ'‰Ã¾Ã¼Ã¸Ã'… 1÷þÃ'„þÃ'€Ã¼ ðýÿþÃ'ÂÃ'‚ðÃ'‚øÃ'ˆÃ² Ã'ŽÃ¾Ã»Ã'Å'þòðýøù Ã'„Ã'€Ã°Ã³Ã¼ÃµÃ½Ã'‚ ÿûð÷üÃ'ˆÃ¾Ã³ÃµÃ½ 'Æ' ÃÅ¡5 òøÃ'ÂòûÃ'Âõ ýðùÿþÃ'‚Ã'Æ'öÃ'ˆÃ'ˆÃ'Æ' Ã'ˆÃ¿Ã±Ã'Æ'òðûÃ'Å'ýÃ'Æ' ðúÃ'‚øòHÄ°CTB Ã'ÂÃ'‚þÃ'Âþòýþ ÿÃ'€Ã¾Ã»1Ã'„õÃ'€Ã°Ã'†Ã¸ õýôþÃ'‚õûÃ'‚ûÃ'Å'ýøÃ'… úû1Ã'‚øý, ÿÃ'€Ã¸Ã³Ã½Ã'ˆÃ'Æ'Ã'ŽÃ'‡Ã¸ ĪĪ Ã'‡ÃµÃ'€ÃµÃ· ðúÃ'‚øòðÃ'‰Ã'Ž üýþÃâ€"ÃÂÃÂÃÂÃÂÃÂ¥ áÃÂÓÃÂðÛìÃÂÃÂÃÂ¥ èÛïÃÂ¥1Ã’, Ã'‰Ã¾ ÿÃ'€Ã¸Ã·Ã²Ã¾Ã´Ã'ÂÃ'‚Ã'Å' ôþ ÷ðóøñõûone úûóóøý Ã'‚ð cynpeciàðýóÃ'ˆÃ³ÃµÃ½ÃµÃ·Ã'Æ'. Ãâ€"ðÃ'ÂÃ'‚þÃ'ÂÃ'Æ'òðýýÃ' Ã°Ã´ÃµÃ½Ã¾Ã²Ã'„Ã'Æ'Ã'Âýþ! óõýõÃ'‚øÃ'‡Ã½Ã¾! úþýÃ'ÂÃ'‚Ã'€Ã'Æ'úÃ'†Ã¸, Ã'‰Ã¾ úþôÃ'Æ'õ ðýóÃ'ˆÃ'ÂÃ'‚ðÃ'‚øý ÃÅ¡5, Ã'Âú ÿõÃ'€Ã'ÂÿõúÃ'‚øòýþóþ ÷ðÃ'ÂþñÃ'Æ' úþÃ'€ÃµÃºÃ'†Ã¸ ÃÂÃâ€"Þ õ Ã'ÂÃ'ÂúÃ'€Ã°Ã²Ã¸Ã¼ ÿÃ'€Ã¸ÃºÃ»Ã°Ã´Ã¾Ã¼ Ã'€ÃµÃ²Ã¾Ã»Ã'ŽÃ'†Ã'ˆÃ½Ã¾Ã³Ã¾ Ã'ˆÃ´Ã'…þôÃ'Æ' ò Ã'‚ðÃ'€Ã³ÃµÃ'‚ýÃ'ˆ óõýýÃ'ˆ Tepami. Òòðöðõüþ ÷ð ôþÃ'‰Ã»Ã'Å'ýõ ÿÃ'€Ã¾Ã²ÃµÃ´ÃµÃ½Ã¸Ã' Ã¿Ã¾Ã´Ã°Ã»Ã'Å'Ã'ˆÃ¸Ã'… úþüÿûõúÃ'ÂýøÃ'… ôþÃ'ÂûÃ'‰Ã¶ÃµÃ½Ã'Å' ôûÃ' Ã·'Ã'ÂÃ'ÂÃ'Æ'òðýýÃ' ÃºÃ»Ã'ˆÃ'ˆÃ½Ã¾Ã³Ã¾ ÿþÃ'‚õýÃ'‰Ã°Ã»Ã'Æ' Ã'‚ð þÿÃ'‚øüðûÃ'Å'ýøÃ'… Ã'€ÃµÃ¶Ã¸MÄ°B òøúþÃ'€Ã¸Ã'ÂÃ'‚ðýýÃ' Ã·Ã°Ã'ÂþñÃ'ˆ ýð ochobàðýóÃ'ŽÃ'ÂÃ'‚ðÃ'‚øýÃ'Æ' ôûÃ' Ã»Ã'ˆÃ'Æ'òðýýÃ' Ã½ÃµÃ¾Ã²Ã°Ã'ÂúÃ'Æ'ûÃ'ÂÃ'€Ã½Ã¸Ã'… ÿðÃ'‚þûþóÃ'ˆ þúð.Alternate abstractÃÂýóøþÃ'ÂÃ'‚ðÃ'‚øýÃ'‹ Ã'ÂþÃ'ÂÃ'‚ðòûÃ'ÂÃ'ŽÃ'‚ óÃ'€Ã'Æ'ÿÿÃ'Æ' úÃ'€Ã¸Ã½Ã³Ã» (ÃÅ¡)-Ã'Âþ ôõÃ'€Ã¶Ã°Ã'‰Ã¸Ã'… ÿÃ'€Ã¾Ã'‚õþûøÃ'‚øÃ'‡ÃµÃ'ÂúøÃ'… Ã'„Ã'€Ã°Ã³Ã¼ÃµÃ½Ã'‚þò ÿûð÷üøýþóõý/ÿûð÷üøýð, úþÃ'‚þÃ'€Ã'‹Ãµ Ã'„Ã'Æ'ýúÃ'†Ã¸Ã¾Ã½Ã¸Ã'€Ã'Æ'Ã'ŽÃ'‚ úðú üþÃ'‰Ã½Ã'‹Ãµ øýóøñøÃ'€Ã'Æ'Ã'ŽÃ'‰Ã¸Ãµ üõôøðÃ'‚þÃ'€Ã'‹ ÿÃ'€Ã¾Ã»Ã¸Ã'„õÃ'€Ã°Ã'†Ã¸Ã¸ ø üøóÃ'€Ã°Ã'†Ã¸Ã¸ Ã'ÂýôþÃ'‚õûøðûÃ'Å'ýÃ'‹Ã'… úûõÃ'‚þú. ÃÂýóøþÃ'ÂÃ'‚ðÃ'‚øýÃ'‹ Ã'Æ'Ã'‡Ã°Ã'ÂÃ'‚òÃ'Æ'Ã'ŽÃ'‚ ò üþôÃ'Æ'ûøÃ'€Ã¾Ã²Ã°Ã½Ã¸Ã¸ Ã'€Ã¾Ã'ÂÃ'‚ð Ã'ÂþÃ'ÂÃ'Æ'ôþò ò Ã'‚úðýÃ'ÂÃ'… ò ýþÃ'€Ã¼Ãµ ø ÿÃ'€Ã¸ Ã'€Ã°Ã·Ã»Ã¸Ã'‡Ã½Ã'‹Ã'… ÿðÃ'‚þûþóøÃ'‡ÃµÃ'ÂúøÃ'… Ã'ÂþÃ'ÂÃ'‚þÃ'ÂýøÃ'ÂÃ'…, ðÃ'ÂÃ'ÂþÃ'†Ã¸Ã¸Ã'€Ã¾Ã²Ã°Ã½Ã½Ã'‹Ã'… Ã' Ã°Ã±ÃµÃ'€Ã'€Ã°Ã½Ã'‚ýþù ýõþòðÃ'ÂúÃ'Æ'ûÃ'ÂÃ'€Ã¸Ã·Ã°Ã'†Ã¸ÃµÃ¹. æõûÃ'Å'Ã'Ž Ã'€Ã°Ã±Ã¾Ã'‚Ã'‹ ñÃ'‹Ã»Ã¾ þñþñÃ'‰ÃµÃ½Ã¸Ãµ øüõÃ'ŽÃ'‰ÃµÃ¹Ã'ÂÃ' Ã¸Ã½Ã'„þÃ'€Ã¼Ã°Ã'†Ã¸Ã¸, òúûÃ'ŽÃ'‡Ã°Ã' Ã'ÂþñÃ'ÂÃ'‚òõýýÃ'‹Ãµ Ã'ÂúÃ'ÂÿõÃ'€Ã¸Ã¼ÃµÃ½Ã'‚ðûÃ'Å'ýÃ'‹Ãµ ôðýýÃ'‹Ãµ ðòÃ'‚þÃ'€Ã¾Ã², þ ÿõÃ'€Ã'ÂÿõúÃ'‚øòðÃ'… ÿÃ'€Ã¸Ã¼ÃµÃ½ÃµÃ½Ã¸Ã' Ã°Ã½Ã³Ã¸Ã¾Ã'ÂÃ'‚ðÃ'‚øýþò ôûÃ' Ã»ÃµÃ'‡ÃµÃ½Ã¸Ã' Ã½ÃµÃ¾Ã²Ã°Ã'ÂúÃ'Æ'ûÃ'ÂÃ'€Ã½Ã'‹Ã'… ÷ðñþûõòðýøù óûð÷ð (ÃÂÃâ€"Ó). ÞÃ'Âýþòýþõ òýøüðýøõ Ã'ÂþÃ'ÂÃ'€ÃµÃ´Ã¾Ã'‚þÃ'‡ÃµÃ½Ã¾ ýð ÿðÃ'‚þûþóøÃ'ÂÃ'… Ã'ÂõÃ'‚Ã'‡Ã°Ã'‚úø ø ÿþòÃ'€ÃµÃ¶Ã´ÃµÃ½Ã¸Ã'ÂÃ'… Ã'€Ã¾Ã³Ã¾Ã²Ã¸Ã'†Ã'‹. Ã’ Ã'‡Ã°Ã'ÂÃ'‚ýþÃ'ÂÃ'‚ø, þÿøÃ'ÂÃ'‹Ã²Ã°Ã'ŽÃ'‚Ã'ÂÃ' Ã´Ã°Ã½Ã½Ã'‹Ãµ ûøÃ'‚õÃ'€Ã°Ã'‚Ã'Æ'Ã'€Ã'‹ þ ÿõÃ'€Ã'ÂÿõúÃ'‚øòýÃ'‹Ã'… ø Ã'€ÃµÃ'‚Ã'€Ã¾Ã'ÂÿõúÃ'‚øòýÃ'‹Ã'… øÃ'ÂÃ'ÂûõôþòðýøÃ'ÂÃ'…, úûøýøÃ'‡ÃµÃ'ÂúøÃ'… øÃ'ÂÿÃ'‹Ã'‚ðýøÃ'ÂÃ'… ø ÿðÃ'‚þÃ'„ø÷øþûþóøÃ'‡ÃµÃ'ÂúøÃ'… öøòþÃ'‚ýÃ'‹Ã'… üþôõûÃ'ÂÃ'…, Ã'Âþ÷ôðýýÃ'‹Ã'… ôûÃ' Ã¸Ã'ÂÃ'ÂûõôþòðýøÃ' Ã¸ ûõÃ'‡ÃµÃ½Ã¸Ã' ÃÂÃâ€"Ó. ÞÃ'ÂþñÃ'‹Ã¹ ðúÃ'†ÃµÃ½Ã'‚ ñÃ'‹Ã» Ã'Âôõûðý ýð ûðñþÃ'€Ã°Ã'‚þÃ'€Ã½Ã'‹Ã'… ÿþôÃ'…þôðÃ'… ú ÿþûÃ'Æ'Ã'‡ÃµÃ½Ã¸Ã'Ž Ã'€Ã°Ã·Ã»Ã¸Ã'‡Ã½Ã'‹Ã'… ø÷þÃ'„þÃ'€Ã¼ ðýóøþÃ'ÂÃ'‚ðÃ'‚øýð, ð Ã'‚ðúöõ ýð Ã'ÂÃ'€Ã°Ã²Ã½ÃµÃ½Ã¸Ã¸ ðýÃ'‚øðýóøþóõýýÃ'‹Ã'… òþ÷üþöýþÃ'ÂÃ'‚õù ýðÃ'‚øòýÃ'‹Ã'… ø Ã'€ µÃºÃ¾Ã¼Ã±Ã¸Ã½Ã°Ã½Ã'‚ýÃ'‹Ã'… ÿþûøÿõÿÃ'‚øôþòðýóøþÃ'ÂÃ'‚ðÃ'‚øýþò. àõ÷Ã'Æ'ûÃ'Å'Ã'‚ðÃ'‚Ã'‹ Ã'ÂõÃ'€Ã¸Ã¸ øÃ'ÂÃ'Âûõôþòðýøù Ã'ÂòøôõÃ'‚õûÃ'Å'Ã'ÂÃ'‚òÃ'Æ'Ã'ŽÃ'‚, Ã'‡Ã'‚þ ðýóøþÃ'ÂÃ'‚ðÃ'‚øýÃ'‹ üþóÃ'Æ'Ã'‚ ÿþûýþÃ'ÂÃ'‚Ã'Å'Ã'Ž ÿþôðòûÃ'ÂÃ'‚Ã'Å' ÿðÃ'‚þûþóøÃ'‡ÃµÃ'Âúøù ðýóøþóõýõ÷ ÿÃ'€Ã¸ ôøðñõÃ'‚øÃ'‡ÃµÃ'Âúþù ÿÃ'€Ã¾Ã»Ã¸Ã'„õÃ'€Ã°Ã'‚øòýþù Ã'€ÃµÃ'‚øýþÿðÃ'‚øø, ýõ òûøÃ'ÂÃ' Ã½Ã° ýþÃ'€Ã¼Ã°Ã
Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Base de dados: ProQuest Central Tipo de estudo: Estudo observacional / Fatores de risco Idioma: Inglês Revista: Biotechnologia Acta Ano de publicação: 2021 Tipo de documento: Artigo
Similares
Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Base de dados: ProQuest Primal Tipo de estudo: Estudo observacional / Fatores de risco Idioma: Inglês Revista: Biotechnologia Acta Ano de publicação: 2021 Tipo de documento: Artigo
Source: https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1136887
0 Response to "Øâ¯ã˜â§ã™â€ Ù„ã™ë†ã˜â¯ Øâ²ã›å’ã˜â±ã™â€ Ùë†ã›å’ã˜â³ Ùâã˜â§ã˜â±ã˜â³ã›å’ Ùâã›å’ã™â€žã™â€¦ Johnny English Strikes Again 2018"
Post a Comment